Treats acute lymphoblastic leukemia (ALL). ANDA 81099, held by Barr Laboratories. Methotrexate Sodium.
As of Nov 21, 2026, ANDA 81099 (Methotrexate Sodium), held by Barr Laboratories, was first approved by FDA on Oct 15, 1990, with 32 approved supplements and 0 published complete response letters.
Methotrexate tablets are a dihydrofolate reductase inhibitor indicated for the: Treatment of adults and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen Treatment of adults with mycosis fungoides Treatment of adults with relapsed or refractory non-Hodgkin lymphoma as part of a metronomic combination regimen Treatment of adults with rheumatoid arthritis Treatment of pediatric patients with polyarticular juvenile idiopathic arthritis (pJIA) Treatment of adults with severe psoriasis 1.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 15, 1990 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Methotrexate SodiumEQ 2.5MG BASE ยท tablet;oral | Methotrexate Sodium | Rx |
| May 27, 2026 | Supplement 53Labeling ยท Standard review | Approved | None posted |
| Jul 3, 2025 | Supplement 49Labeling ยท Standard review | Approved | None posted |
| Oct 20, 2020 | Supplement 45Labeling ยท Standard review | Approved | None posted |
| Oct 20, 2020 | Supplement 41Labeling ยท Standard review | Approved | None posted |
| Oct 20, 2020 | Supplement 39Labeling ยท Standard review | Approved | None posted |
| Aug 2, 2010 | Supplement 35Labeling | Approved | None posted |
| Aug 22, 2002 | Supplement 27Labeling | Approved | None posted |
| Aug 22, 2002 | Supplement 26Labeling | Approved | None posted |
| Dec 20, 2000 | Supplement 24Manufacturing | Approved | None posted |
| Aug 10, 2000 | Supplement 25Labeling | Approved | None posted |
| Dec 21, 1999 | Supplement 23Manufacturing | Approved | None posted |
| Dec 6, 1999 | Supplement 22Manufacturing | Approved | None posted |
| Jul 6, 1999 | Supplement 21Manufacturing | Approved | None posted |
| Jul 6, 1999 | Supplement 20Labeling | Approved | None posted |
| Jul 6, 1999 | Supplement 19Manufacturing | Approved | None posted |
| May 20, 1999 | Supplement 18Manufacturing | Approved | None posted |
| Dec 1, 1998 | Supplement 14Manufacturing | Approved | None posted |
| Nov 20, 1998 | Supplement 17Manufacturing | Approved | None posted |
| Nov 20, 1998 | Supplement 16Manufacturing | Approved | None posted |
| Nov 20, 1998 | Supplement 15Manufacturing | Approved | None posted |
| Aug 17, 1998 | Supplement 13Manufacturing | Approved | None posted |
| Jun 9, 1998 | Supplement 12Labeling | Approved | None posted |
| Oct 30, 1997 | Supplement 11Manufacturing | Approved | None posted |
| Apr 18, 1996 | Supplement 9Manufacturing | Approved | None posted |
| Apr 3, 1996 | Supplement 10Manufacturing | Approved | None posted |
| Dec 23, 1994 | Supplement 8Manufacturing | Approved | None posted |
| Sep 26, 1994 | Supplement 4Labeling | Approved | None posted |
| Sep 26, 1994 | Supplement 3Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 7Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 5Manufacturing | Approved | None posted |
| Dec 19, 1991 | Supplement 2Labeling | Approved | None posted |
| May 10, 1991 | Supplement 1Manufacturing | Approved | None posted |
| Oct 15, 1990 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. โWhat FDA's review saysโ is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters